BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71
376 results:

  • 1. Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital.
    Ligero-López J; Sánchez-Castellano MÁ; Falces-Romero I; Montero-Vega MD; García-Rodríguez J
    J Neurovirol; 2023 Oct; 29(5):598-604. PubMed ID: 37470903
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pathology for severe inflammatory pml with PD1/PD-L1 expression of favorable prognosis: What's a prognostic factor for pml-IRIS?
    Shishido-Hara Y; Akimoto J; Fukami S; Kohno M; Matsubayashi J; Nagao T
    Neuropathology; 2024 Feb; 44(1):47-58. PubMed ID: 37424276
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study.
    Bringhen S; Pour L; Benjamin R; Grosicki S; Min CK; C de Farias DL; Vorog A; Labotka RJ; Wang B; Cherepanov D; Cain LE; Manne S; Rajkumar SV; Dimopoulos MA
    Clin Lymphoma Myeloma Leuk; 2023 Jul; 23(7):491-504. PubMed ID: 37149398
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-κB activation and survival.
    Hleihel R; Skayneh H; de Thé H; Hermine O; Bazarbachi A
    Blood Cancer J; 2023 May; 13(1):67. PubMed ID: 37137914
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An autopsy case of progressive multifocal leukoencephalopathy with massive iron deposition in juxtacortical lesions.
    Okamoto K; Takeda A; Hatsuta H; Sano T; Takao M; Ohsawa M; Miki Y; Nakamichi K; Itoh Y
    Neuropathology; 2023 Oct; 43(5):396-402. PubMed ID: 36847459
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Amide proton transfer MRI differentiates between progressive multifocal leukoencephalopathy and malignant brain tumors: a pilot study.
    Koike H; Morikawa M; Ishimaru H; Ideguchi R; Uetani M; Hiu T; Matsuo T; Miyoshi M
    BMC Med Imaging; 2022 Dec; 22(1):227. PubMed ID: 36572873
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Fatal neurological side effect of anti-CD20 antibody treatment].
    Schmidt K; Skusa R; Großmann A
    Inn Med (Heidelb); 2023 Feb; 64(2):193-196. PubMed ID: 36422661
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Human Immunodeficiency Virus: Opportunistic Infections and Beyond.
    Siripurapu R; Ota Y
    Neuroimaging Clin N Am; 2023 Feb; 33(1):147-165. PubMed ID: 36404041
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Progressive multifocal leukoencephalopathy in anti-CD20 and other monoclonal antibody (mAb) therapies used in multiple sclerosis: A review.
    Sharma K; Tolaymat S; Yu H; Elkhooly M; Jaiswal S; Jena A; Kakara M; Sriwastava S
    J Neurol Sci; 2022 Dec; 443():120459. PubMed ID: 36283150
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cinobufagin induces acute promyelocytic leukaemia cell apoptosis and pml-RARA degradation in a caspase-dependent manner by inhibiting the β-catenin signalling pathway.
    Bian Y; Xue M; Guo X; Jiang W; Zhao Y; Zhang Z; Wang X; Hu Y; Zhang Q; Dun W; Zhang L
    Pharm Biol; 2022 Dec; 60(1):1801-1811. PubMed ID: 36121296
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Progressive Multifocal Leukoencephalopathy in Relapsed Ph+ Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review.
    Edahiro T; Fukushima N; Otani T; Nakamori M; Nakamichi K; Chishaki R; Fujino K; Mino T; Yoshida T; Sugihara S; Nishizawa M; Ichinohe T
    Acta Haematol; 2022; 145(6):655-661. PubMed ID: 35896078
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Various types of electrochemical biosensors for leukemia detection and therapeutic approaches.
    Chupradit S; Km Nasution M; Rahman HS; Suksatan W; Turki Jalil A; Abdelbasset WK; Bokov D; Markov A; Fardeeva IN; Widjaja G; Shalaby MN; Saleh MM; Mustafa YF; Surendar A; Bidares R
    Anal Biochem; 2022 Oct; 654():114736. PubMed ID: 35588855
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Progressive multifocal leukoencephalopathy during the treatment for mycosis fungoides].
    Sawayama Y; Kato T; Watanabe H; Yamada Y; Fujioka M; Sato S; Baba M; Ando K; Miyazaki T; Kamio Y; Nakamichi K; Yukitake M; Imaizumi Y; Miyazaki Y
    Rinsho Ketsueki; 2022; 63(3):206-210. PubMed ID: 35387934
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab.
    Boesl F; Allers K; Herm J; Scheider T; Franke C
    J Neurovirol; 2022 Apr; 28(2):335-338. PubMed ID: 35320511
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies.
    Diamantopoulos PT; Kalopisis K; Tsatsou A; Efthymiou A; Giannakopoulou N; Hatzidavid S; Viniou NA
    Eur J Haematol; 2022 May; 108(5):359-368. PubMed ID: 35100451
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy post ibrutinib therapy in relapsed chronic lymphocytic leukaemia.
    Tahir F; Sy J; Reddel S; Trotman J
    Leuk Lymphoma; 2022 Jun; 63(6):1464-1468. PubMed ID: 35037559
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cerebral lesions in hematological malignancies: a case report.
    D'Ettore N; Scheggi V; Alterini B; Marchionni N
    J Med Case Rep; 2021 Dec; 15(1):603. PubMed ID: 34924018
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Progressive multifocal leukoencephalopathy in patients with immunovirological control and at least 6 months of combination antiretroviral therapy.
    Dalla-Pozza P; Hentzien M; Allavena C; Doe de Maindreville A; Bouiller K; Valantin MA; Lafont E; Zaegel-Faucher O; Cheret A; Martin-Blondel G; Cotte L; Bani-Sadr F;
    AIDS; 2022 Mar; 36(4):539-549. PubMed ID: 34873087
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy.
    Ramos Perez JM; Patel KP; Loghavi S; Garcia-Manero G; Borthakur G; Jabbour E; Wierda W; Pierce S; Brandt M; Kornblau S; Kadia T; Daver N; DiNardo CD; Jain N; Yilmaz M; Short N; Verstovsek S; Ferrajoli A; Andreeff M; Konopleva M; Rivera D; McCue D; Kantarjian HM; Ravandi F
    Leuk Lymphoma; 2022 Mar; 63(3):672-675. PubMed ID: 34668451
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A case of intravascular large B cell lymphoma with brain involvement mimicking progressive multifocal leukoencephalopathy.
    Belli E; Milano C; Pesaresi I; Trivelli I; Tavoni A; Ciancia E; Alì G; Zampa V; Pizzanelli C; Siciliano G; Ricci G
    Int J Neurosci; 2023 Jul; 133(7):735-739. PubMed ID: 34425062
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.